Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

minibody

  • Single Chelator–Minibody Theranostic Agents for <sup>89</sup>Zr PET Imaging and <sup>177</sup>Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer
    Open Access
    Single Chelator–Minibody Theranostic Agents for 89Zr PET Imaging and 177Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer
    Khanh-Van Ho, David S. Tatum, Lisa Watkinson, Terry Carmack, Fang Jia, Alessandro Mascioni, Charles A. Maitz, Darren Magda and Carolyn J. Anderson
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1435-1442; DOI: https://doi.org/10.2967/jnumed.124.267667
  • CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
    You have access
    CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
    Michael D. Farwell, Raymond F. Gamache, Hasan Babazada, Matthew D. Hellmann, James J. Harding, Ron Korn, Alessandro Mascioni, William Le, Ian Wilson, Michael S. Gordon, Anna M. Wu, Gary A. Ulaner, Jedd D. Wolchok, Michael A. Postow and Neeta Pandit-Taskar
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 720-726; DOI: https://doi.org/10.2967/jnumed.121.262485
  • You have access
    First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
    Neeta Pandit-Taskar, Michael A. Postow, Matthew D. Hellmann, James J. Harding, Christopher A. Barker, Joseph A. O’Donoghue, Martha Ziolkowska, Shutian Ruan, Serge K. Lyashchenko, Frank Tsai, Michael Farwell, Tara C. Mitchell, Ron Korn, William Le, Jason S. Lewis, Wolfgang A. Weber, Deepak Behera, Ian Wilson, Michael Gordon, Anna M. Wu and Jedd D. Wolchok
    Journal of Nuclear Medicine April 1, 2020, 61 (4) 512-519; DOI: https://doi.org/10.2967/jnumed.119.229781
  • You have access
    First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
    Neeta Pandit-Taskar, Joseph A. O’Donoghue, Shutian Ruan, Serge K. Lyashchenko, Jorge A. Carrasquillo, Glenn Heller, Danny F. Martinez, Sarah M. Cheal, Jason S. Lewis, Martin Fleisher, Jennifer S. Keppler, Robert E. Reiter, Anna M. Wu, Wolfgang A. Weber, Howard I. Scher, Steven M. Larson and Michael J. Morris
    Journal of Nuclear Medicine December 1, 2016, 57 (12) 1858-1864; DOI: https://doi.org/10.2967/jnumed.116.176206
  • You have access
    Photoimmunotherapy Targeting Prostate-Specific Membrane Antigen: Are Antibody Fragments as Effective as Antibodies?
    Rira Watanabe, Hirofumi Hanaoka, Kazuhide Sato, Tadanobu Nagaya, Toshiko Harada, Makoto Mitsunaga, Insook Kim, Chang H. Paik, Anna M. Wu, Peter L. Choyke and Hisataka Kobayashi
    Journal of Nuclear Medicine January 1, 2015, 56 (1) 140-144; DOI: https://doi.org/10.2967/jnumed.114.149526
  • You have access
    Improved Modeling of In Vivo Kinetics of Slowly Diffusing Radiotracers for Tumor Imaging
    Moses Q. Wilks, Scott M. Knowles, Anna M. Wu and Sung-Cheng Huang
    Journal of Nuclear Medicine September 1, 2014, 55 (9) 1539-1544; DOI: https://doi.org/10.2967/jnumed.114.140038
  • You have access
    Quantitative ImmunoPET of Prostate Cancer Xenografts with 89Zr- and 124I-Labeled Anti-PSCA A11 Minibody
    Scott M. Knowles, Kirstin A. Zettlitz, Richard Tavaré, Matthew M. Rochefort, Felix B. Salazar, David B. Stout, Paul J. Yazaki, Robert E. Reiter and Anna M. Wu
    Journal of Nuclear Medicine March 1, 2014, 55 (3) 452-459; DOI: https://doi.org/10.2967/jnumed.113.120873
SNMMI

© 2025 SNMMI

Powered by HighWire